These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 31302740

  • 21. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
    Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
    Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
    [Abstract] [Full Text] [Related]

  • 22. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Sun Y, Liu J, Geng Z, Tao Y, Zheng F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2020 Mar 17; 18(1):23. PubMed ID: 32183825
    [Abstract] [Full Text] [Related]

  • 23. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Mar 17; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 24. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
    Shimizu M, Mizuta M, Usami M, Inoue N, Sakakibara Y, Yamada K, Konishi M, Ohta K, Yachie A.
    Cytokine; 2018 Aug 17; 108():168-172. PubMed ID: 29625336
    [Abstract] [Full Text] [Related]

  • 25. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
    Eur J Pediatr; 2019 Mar 17; 178(3):315-322. PubMed ID: 30499051
    [Abstract] [Full Text] [Related]

  • 26. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 Mar 17; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 27. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug 17; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 28. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 17; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 29. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
    Rheumatol Int; 2019 Aug 17; 39(8):1343-1349. PubMed ID: 31139951
    [Abstract] [Full Text] [Related]

  • 30. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N, Gao Y, Wang Y, Dai Y, Tang Y, Huang J, Sun L, Qian G, Ma J, Li X, Liu Y, Yang D, Huang X, Wang W, Li W, Zhuo W, Lv H, Liu Z.
    Int Immunopharmacol; 2024 Sep 30; 139():112698. PubMed ID: 39029232
    [Abstract] [Full Text] [Related]

  • 31. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
    Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
    J Pediatr (Rio J); 2023 Sep 30; 99(4):406-412. PubMed ID: 36977496
    [Abstract] [Full Text] [Related]

  • 32. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 30; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 33. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
    Int J Clin Pract; 2022 Nov 30; 2022():2726686. PubMed ID: 35989868
    [Abstract] [Full Text] [Related]

  • 34. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
    Wang L, Yang Y, Cui Q, Cui Y, Li Q, Che X, Wang C, Quan P, Hu X.
    J Investig Med; 2021 Jan 30; 69(1):13-19. PubMed ID: 33004469
    [Abstract] [Full Text] [Related]

  • 35. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
    Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
    Pediatr Int; 2016 Mar 30; 58(3):180-184. PubMed ID: 26222760
    [Abstract] [Full Text] [Related]

  • 36. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY, Han MY, Cha SH, Jeon YB.
    Pediatr Cardiol; 2013 Mar 30; 34(8):1837-43. PubMed ID: 23744100
    [Abstract] [Full Text] [Related]

  • 37. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G, Masi L, Giani T, Piscitelli E, Cimaz R, Vierucci S, Brandi ML, Falcini F.
    J Rheumatol; 2005 Nov 30; 32(11):2233-8. PubMed ID: 16265708
    [Abstract] [Full Text] [Related]

  • 38. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
    Rheumatol Int; 2016 Jul 30; 36(7):905-10. PubMed ID: 27215220
    [Abstract] [Full Text] [Related]

  • 39. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    J Pediatr; 2022 Jan 30; 240():158-163.e4. PubMed ID: 34461064
    [Abstract] [Full Text] [Related]

  • 40. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 30; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.